Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Natl Cancer Inst ; 109(6)2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28040797

RESUMO

Background: A nontoxic chemopreventive intervention efficacious against different subtypes of breast cancer is still a clinically unmet need. The present study was undertaken to determine the efficacy of an Ayurvedic medicine phytochemical (Withaferin A, [WA]) for chemoprevention of breast cancer and to elucidate its mode of action. Methods: Chemopreventive efficacy of WA (4 and 8 mg/kg body weight) was determined using a rat model of breast cancer induced by N-methyl-N-nitrosourea (MNU; n = 14 for control group, n = 15 for 4 mg/kg group, and n = 18 for 8 mg/kg group). The mechanisms underlying breast cancer chemoprevention by WA were elucidated by immunoblotting, biochemical assays, immunohistochemistry, and cytokine profiling using plasma and tumors from the MNU-rat (n = 8-12 for control group, n = 7-11 for 4 mg/kg group, and n = 8-12 for 8 mg/kg group) and/or mouse mammary tumor virus-neu (MMTV-neu) models (n = 4-11 for control group and n = 4-21 for 4 mg/kg group). Inhibitory effect of WA on exit from mitosis and leptin-induced oncogenic signaling was determined using MCF-7 and/or MDA-MB-231 cells. All statistical tests were two-sided. Results: Incidence, multiplicity, and burden of breast cancer in rats were decreased by WA administration. For example, the tumor weight in the 8 mg/kg group was lower by about 68% compared with controls (8 mg/kg vs control, mean = 2.76 vs 8.59, difference = -5.83, 95% confidence interval of difference = -9.89 to -1.76, P = .004). Mitotic arrest and apoptosis induction were some common determinants of breast cancer chemoprevention by WA in the MNU-rat and MMTV-neu models. Cytokine profiling showed suppression of plasma leptin levels by WA in rats. WA inhibited leptin-induced oncogenic signaling in cultured breast cancer cells. Conclusions: WA is a promising chemopreventative phytochemical with the ability to inhibit at least two different subtypes of breast cancer.


Assuntos
Neoplasias da Mama/prevenção & controle , Neoplasias Mamárias Experimentais/prevenção & controle , Vírus do Tumor Mamário do Camundongo , Infecções por Retroviridae/complicações , Infecções Tumorais por Vírus/complicações , Vitanolídeos/uso terapêutico , 8-Hidroxi-2'-Desoxiguanosina , Acetilcoenzima A/sangue , Família Aldeído Desidrogenase 1 , Animais , Apoptose/efeitos dos fármacos , Biomarcadores Tumorais/análise , Neoplasias da Mama/induzido quimicamente , Neoplasias da Mama/química , Neoplasias da Mama/patologia , Ciclo Celular/efeitos dos fármacos , Citocinas/sangue , Desoxiguanosina/análogos & derivados , Desoxiguanosina/análise , Complexo III da Cadeia de Transporte de Elétrons/metabolismo , Feminino , Fatores de Transcrição Forkhead/análise , Humanos , Antígeno Ki-67/análise , Ácido Láctico/sangue , Leptina/sangue , Células MCF-7 , Malatos/sangue , Neoplasias Mamárias Experimentais/química , Neoplasias Mamárias Experimentais/patologia , Neoplasias Mamárias Experimentais/virologia , Metilnitrosoureia , Camundongos , Mitose/efeitos dos fármacos , Índice Mitótico , Ratos , Receptores de Estrogênio/análise , Retinal Desidrogenase/análise , Transdução de Sinais/efeitos dos fármacos , Carga Tumoral , Vitanolídeos/análise , Vitanolídeos/farmacologia
2.
Cancer Biol Ther ; 14(6): 521-6, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23760494

RESUMO

There seems to be little doubt that organosulfur compounds have enormous benefits for biological processes, especially those of diseases like cancer. The preliminary results herein define a cancer model in which benefits/mechanisms of multitudes of xenobiotic and nature's organosulfurs could easily be compared. Mice from three strains with a high incidence for naturally occurring tumors were treated daily with 2-mercaptoethanol (2-Me) starting at weaning. The 100% tumor incidence of undefined etiology in untreated BXSB-Yaa (+) males was completely prevented by 2-Me. In contrast, 2-Me treatment of female and male C3H.OL and C3H.OH congenic strains, did not change the 100% tumor incidence due to milk-borne retrovirus, MMTV(S), but did: (1) delay the appearance of tumors by 42%; (2) increase longevity 56%; and (3) increase longevity, post-tumor detection, 95%. The addition of these results to the increasingly impressive anti-cancer benefits of simple xenobiotic organosulfurs raise the question: Can they be adapted for use as a preventive modality for human cancer?


Assuntos
Anticarcinógenos/administração & dosagem , Neoplasias Mamárias Experimentais/prevenção & controle , Vírus do Tumor Mamário do Camundongo , Mercaptoetanol/administração & dosagem , Infecções por Retroviridae/complicações , Infecções Tumorais por Vírus/complicações , Administração Oral , Animais , Suplementos Nutricionais , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Masculino , Neoplasias Mamárias Experimentais/virologia , Camundongos , Camundongos Endogâmicos C3H , Camundongos Transgênicos , Resultado do Tratamento
3.
Blood ; 88(7): 2385-409, 1996 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-8839829
4.
Postgrad Med ; 96(6): 73-6, 79-81, 1994 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-7971614

RESUMO

Neither Epstein-Barr virus nor human herpesvirus 6 appears to play a causative role in chronic fatigue syndrome. The possibility that a novel human retrovirus may be present in patients with the syndrome needs further study. A number of abnormalities found in patients with chronic fatigue syndrome point to central nervous system (CNS) involvement. These include immunologic abnormalities, indications of pituitary and hypothalamic involvement, abnormal basal plasma levels of certain neurotransmitter metabolites, and cerebral perfusion abnormalities. The symptom pattern of chronic fatigue syndrome may eventually be explainable in terms of CNS dysfunction.


Assuntos
Síndrome de Fadiga Crônica/etiologia , Encefalopatias/complicações , Transtornos Cerebrovasculares/complicações , Humanos , Hipotálamo , Doenças do Sistema Imunitário/complicações , Neurotransmissores/análise , Doenças da Hipófise/complicações , Infecções por Retroviridae/complicações
5.
Carcinogenesis ; 13(10): 1811-6, 1992 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1330343

RESUMO

Retrovirally induced immunosuppression may elevate the incidence of chemically induced cancers. A proposed hypothesis to explain this relationship is the increased free radical activity observed during retroviral infection and carcinogen activation. We previously found that vitamin E retarded growth of esophageal tumors accompanied by reductions of free radical products. This study investigated the contribution that retroviral immunosuppression has on esophageal cancer induced by the carcinogen N-nitrosomethylbenzylamine (NMBzA), and the response that increased levels of dietary vitamin E has on this induced carcinogenesis. Female C57BL/6 mice received NMBzA or vehicle (corn oil) i.p. weekly for 3 weeks. Then some of the mice were infected with LP-BM5 murine retrovirus and fed diets containing 30 IU vitamin E or 172 IU vitamin E/kg of diet. As an assessment of free radical activity, exhaled ethane was measured prior to killing the animals at 26 weeks. Esophagi from the various mice groups were assessed for size and frequency of tumors. Livers homogenates were analyzed for vitamins A and E, lipid fluorescence, conjugated dienes and malondialdehyde. Hepatic levels of vitamin A and E were decreased (P < 0.05) and indices of lipid peroxidation were greater (P < 0.05) in NMBzA-treated mice relative to controls. Lipid peroxidation and serum transaminases (ALT and AST) were greatest in mice given NMBzA and infected with the retroviruses. Incidence of esophageal tumors were also greatest in the NMBzA-treated, immunocompromised animals. Mice fed vitamin E-supplemented diets showed increased (P < 0.05) hepatic concentrations of vitamin E and vitamin A, decreased activities of serum transaminases, decreased indices of lipid peroxidation, and decreased size and frequency of esophageal tumors in both the immunocompromised and non-immunocompromised mice. These results suggest that vitamin E plays an antioxidant function that retards the incidence of esophageal cancers in immunocompromised and non-immunocompromised animals.


Assuntos
Dimetilnitrosamina/análogos & derivados , Neoplasias Esofágicas/prevenção & controle , Hospedeiro Imunocomprometido/imunologia , Síndrome de Imunodeficiência Adquirida Murina/imunologia , Infecções por Retroviridae/imunologia , Vitamina E/uso terapêutico , Animais , Carcinógenos , Doença Hepática Induzida por Substâncias e Drogas , Neoplasias Esofágicas/induzido quimicamente , Neoplasias Esofágicas/microbiologia , Feminino , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Hepatopatias/metabolismo , Linfonodos/anatomia & histologia , Linfonodos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos BALB C , Síndrome de Imunodeficiência Adquirida Murina/complicações , Tamanho do Órgão/efeitos dos fármacos , Infecções por Retroviridae/complicações , Baço/anatomia & histologia , Baço/efeitos dos fármacos , Vitamina A/metabolismo , Vitamina E/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA